GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FINW · Sep 30, 2025

Finwise Bancorp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001856365-25-000045Bank
Sequential deposit growth54thOwn-history percentile · N=13
Evidence method

Sequential · gp.financial.deposits

7.42% · CORE · VALID

Net-income growth100thOwn-history percentile · N=10
Evidence method

Yoy · gp.fundamentals.net_income

41.60% · CORE · VALID

Interest-income growth80thOwn-history percentile · N=10
Evidence method

Yoy · gp.financial.interest_income

26.64% · CORE · VALID

Cash and equivalents50thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.cash

$105.6M · CORE · VALID

Sequential loan growth23thOwn-history percentile · N=13
Evidence method

Sequential · gp.financial.loans

5.34% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History17 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
4.86%
Current
7.42%
Delta
2.57%
Earnings Growth Increased
Previous
28.84%
Current
41.60%
Delta
12.77%
Interest Income Growth Increased
Previous
7.17%
Current
26.64%
Delta
19.48%
Liquidity Increased
Previous
$90.1M
Current
$105.6M
Delta
$15.5M
Loan Growth Decreased
Previous
7.22%
Current
5.34%
Delta
-1.88%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.